查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1716881

心臟POC檢測設備市場（依產品類型、應用和最終用戶）－2025-2030年全球預測

Cardiac POC Testing Devices Market by Product, Device Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計心臟 POC 檢測設備市場規模在 2023 年將達到 13.6 億美元，在 2024 年將達到 15.2 億美元，預計年複合成長率為 12.36%，到 ​​2030 年將達到 30.8 億美元。

主要市場統計數據
基準年2023年 13.6億美元
預計2024年 15.2億美元
預測年份 2030 30.8億美元
複合年成長率（%） 12.36%

由於技術進步、臨床需求變化以及對更快、更可靠診斷的需求等因素的共同作用，心臟照護現場(POC) 檢測市場得到了快速發展。這個充滿活力的領域正在重新定義醫療保健提供者篩檢、診斷和管理心臟病的方式。生物標記檢測和可攜式設備工程的最新趨勢已經產生了在床邊或遠端位置快速評估心臟健康的高效方法。

診斷技術的創新和精確對於及時介入心臟緊急情況至關重要。隨著患者照護趨勢轉向分散和以患者為中心的模式，心臟 POC 測試設備的相關性和應用正在擴大。隨著先進的生物標記測試和複雜的儀器工程的整合滿足了提高準確性和操作靈活性的迫切需求，這些設備的前景有望繼續轉型和成長。

本全面概述從各個角度審視了心臟 POC 測試市場，揭示了不斷變化的市場變化、詳細的細分見解、區域商業機會、主要企業、可行的戰略建議，以及對決策者利用這些趨勢的強烈呼籲。

重新定義心臟POC檢測的變革性轉變

近年來，在技術突破和臨床需求變化的推動下，心臟 POC 檢測領域發生了變化。技術創新的激增促進了新診斷方法的開發，以增強對心臟病的早期發現和持續監測。這種轉變體現在準確性、速度的提高以及向患者更近距離地提供檢測解決方案的能力，最終有助於改善患者的治療效果。

這項變化的關鍵促進因素包括數位健康工具和人工智慧輔助診斷的整合，這簡化了結果的解釋並實現了更個人化的治療途徑。小型化和感測器技術的進步使得設備更加可攜式、更易於使用，增強了它們在各種醫療保健環境中的作用。此外，專注於減少心臟生物標記檢測的周轉時間以及自動化系統的整合有助於減少關鍵時刻的診斷延遲。

這些動態變化正在創造一種市場環境，在這種環境中，快速、準確的診斷不僅​​是可取的，而且是必不可少的。隨著全球醫療保健系統不斷追求更高的效率和更好的患者照護，設備功能和診斷準確性的不斷改進無疑將樹立未來的標準並為市場成長鋪平新的道路。

市場區隔分析的關鍵見解

了解市場區隔的複雜層次結構為識別心臟 POC 測試市場中的機會和挑戰提供了堅實的框架。根據產品，市場分為心臟生物標記測試、耗材及配件、以及設備等部分。心臟生物標記測試部分進一步細分為特定測試，例如 B 型利鈉肽、肌酸激酶同工酶 (CK-MB) 分數、D-二聚體測試、肌紅蛋白測試和肌鈣蛋白測試。同時，透過分析儀器和成像與監控設備的視角探索設備部分，強調分析性能和即時監控能力的重要性。

從設備類型來看，市場可分為桌上型 POC 設備、手持式 POC 設備和穿戴式 POC 設備，每種設備根據臨床需求、便攜性和易用性都有各自的優點和缺點。基於應用的細分進一步將市場分類為診斷和篩檢以及監測，反映了這些設備在心臟病的早期檢測和持續管理中發揮的雙重作用。此外，根據最終用戶（分為門診手術中心、診斷實驗室、家庭環境和醫院）進行的分析，突顯了這些技術在各種護理環境中的多種用途。

這種細粒度的細分策略將技術規格與實際應用相結合，以揭示關鍵趨勢和要求。這使得相關人員不僅能夠了解所提供產品的技術多樣性，還能了解採用這些診斷創新的各種臨床環境。這些見解為制定針對每個細分市場細微需求的針對性策略鋪平了道路，確保產品開發和上市符合新興市場需求和患者照護模式。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球心臟病盛行率和老齡人口成長
      • 致力於早期發現與診斷患者
      • 政府積極支持心臟健康
    • 限制因素
      • 心臟POC檢測設備產品召回的潛在風險
    • 機會
      • 推出基於肌鈣蛋白的新型專有測試
      • 積極的投資和Start-Ups生態系統
    • 任務
      • 心臟POC檢測設備準確性的限制和擔憂
  • 市場區隔分析
    • 產品：一系列心臟 POC 檢測設備的監管核准
    • 設備類型：探索提供便利的居家照護的穿戴式 POC 設備
    • 應用：有效的診斷和篩檢程序在心臟病管理中發揮關鍵作用
    • 最終使用者：醫院提供的全面綜合護理，改善心臟健康
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章心臟POC檢測設備市場（依產品）

  • 心臟生物標記檢測
    • B型利鈉肽
    • 肌酸激酶同工酶 [CK-MB] 分數
    • D-二聚體檢測
    • 肌紅蛋白檢測
    • 肌鈣蛋白檢測
  • 耗材及配件
  • 裝置
    • 分析儀
    • 影像和監控設備

7. 心臟POC檢測設備市場（依設備類型）

  • 桌上型 POC 設備
  • 手持式POC設備
  • 穿戴式POC設備

第 8 章：心臟 POC 測試設備市場（按應用）

  • 診斷和篩檢
  • 監控

第 9 章：心臟 POC 測試設備市場（依最終用戶）

  • 門診手術中心
  • 診斷實驗室
  • 主頁設定
  • 醫院

第 10 章：美洲心臟 POC 測試設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第 11 章亞太心臟 POC 測試設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12. 歐洲、中東和非洲心臟POC檢測設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cipla Limited
  • Compagnie Merieux Alliance SAS
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • LifeSign LLC
  • Medtronic plc
  • Merck KGaA
  • Nano-Ditech Corp.
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • Polymer Technology Systems, Inc. by Sinocare
  • Precision Biosensor, Inc.
  • QuidelOrtho Corporation
  • Sekisui Chemical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen, SA
Product Code: MRR-02026C4CB4BE

The Cardiac POC Testing Devices Market was valued at USD 1.36 billion in 2023 and is projected to grow to USD 1.52 billion in 2024, with a CAGR of 12.36%, reaching USD 3.08 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.52 billion
Forecast Year [2030] USD 3.08 billion
CAGR (%) 12.36%

The cardiac point-of-care (POC) testing market has evolved rapidly, driven by a confluence of technological advances, changing clinical needs, and demand for faster, reliable diagnostics. This dynamic field is redefining the way healthcare providers screen, diagnose, and manage cardiac conditions. Recent developments in biomarker detection and portable device engineering have resulted in highly efficient methods to rapidly assess cardiac health at the bedside or in remote settings.

Innovation and precision in diagnostic technology have become crucial for ensuring timely intervention in cardiac emergencies. As trends in patient care shift towards decentralization and patient-centric models, the relevance and applications of cardiac POC testing devices are expanding. The landscape for these devices is continuously set to experience transformative growth as the integration of advanced biomarker tests and sophisticated device engineering meets an urgent need for improved accuracy and operational flexibility.

This comprehensive overview explores the various angles of the cardiac POC testing market, shedding light on transformative market shifts, detailed segmentation insights, regional opportunities, major players, actionable strategic recommendations, and a persuasive call-to-action for decision-makers looking to capitalize on these developments.

Transformative Shifts Redefining Cardiac POC Testing

In recent years, the cardiac POC testing domain has undergone transformative shifts propelled by both technological breakthroughs and changes in clinical demand. A surge in innovation has led to the development of novel diagnostic methods that enhance early detection and ongoing monitoring of cardiac conditions. This transformation is marked by improvements in accuracy, speed, and the ability to deliver near-patient testing solutions, which ultimately contribute to better patient outcomes.

Key drivers of this shift include the integration of digital health tools and AI-assisted diagnostics, which are streamlining result interpretation and enabling more personalized treatment pathways. Advances in miniaturization and sensor technology have allowed instruments to become more portable and user-friendly, elevating their role across diverse healthcare settings. Furthermore, the focus on reducing the turnaround time for cardiac biomarker tests, alongside the integration of automated systems, is instrumental in mitigating diagnostic delays during critical periods.

These dynamic changes are shaping a market environment where rapid and accurate diagnosis is not just desirable but essential. As healthcare systems globally continue to strive for efficiency and improved patient care, the ongoing enhancements in device capabilities and diagnostic accuracy will undoubtedly set future standards and open up new avenues for market growth.

Key Insights from Market Segmentation Analysis

Understanding the intricate layers of market segmentation provides a robust framework for identifying opportunities and challenges within the cardiac POC testing market. An analysis based on product differentiates the market into segments such as Cardiac Biomarker Test, Consumables & Accessories, and Devices. The Cardiac Biomarker Test segment is itself subdivided further into specific tests including B-Type Natriuretic Peptide, Creatine Kinase-MB (CK-MB) Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. Meanwhile, the Devices segment is examined through the lens of Analyzers and Imaging & Monitoring Devices, highlighting the importance of both analytical performance and real-time monitoring capabilities.

Examining the market by device type exposes a division into Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices, each offering unique pros and cons based on clinical needs, portability, and ease-of-use. The application-based segmentation further divides the market into Diagnostics & Screening and Monitoring, reflecting the dual roles these devices serve in both early detection and ongoing management of cardiac conditions. Additionally, an analysis by end-user segments into Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals, emphasizing the versatile utilization of these technologies across a spectrum of care environments.

This granular segmentation strategy illuminates key trends and requirements by blending technical specifications with practical applications. It helps stakeholders appreciate not only the technical diversity of the offerings but also the varied clinical settings that are adopting these diagnostic innovations. Such insights pave the way for targeted strategies that address the nuanced needs of each segment, ensuring that product development and market positioning are aligned with evolving clinical demands and patient-care paradigms.

Based on Product, market is studied across Cardiac Biomarker Test, Consumable & Accessories, and Devices. The Cardiac Biomarker Test is further studied across B-Type Natriuretic Peptide, Creatine Kinase-MB [CK-MB] Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. The Devices is further studied across Analyzers and Imaging & Monitoring Devices.

Based on Device Type, market is studied across Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices.

Based on Application, market is studied across Diagnostics & Screening and Monitoring.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals.

Regional Insights Driving Market Expansion

The global market for cardiac POC testing is shaped significantly by regional dynamics that influence both technology adoption and regulatory frameworks. In the Americas, robust healthcare infrastructure coupled with a strong focus on innovation in diagnostics fuels the pace of adoption while meeting high clinical standards. The region is characterized by a mature market environment with significant investments in research and development aimed at refining cardiac biomarker tests and associated devices.

Across Europe, the Middle East, and Africa, there is a growing acknowledgment of the importance of decentralized testing solutions, underpinned by strategic government initiatives and supportive healthcare policies. Sophisticated healthcare networks and a rising emphasis on patient monitoring have contributed to the expansion of POC testing solutions in this region. In particular, improving accessibility and reducing diagnostic time barriers have been pivotal in driving market penetration.

The Asia-Pacific region presents a dynamic growth landscape, characterized by rapid urbanization, rising healthcare awareness, and significant efforts to upgrade medical infrastructure. Emerging economies in this area have witnessed accelerated investments in healthcare technology, while simultaneous policy reforms and technological adoptions are enhancing access to advanced diagnostics. The region remains a hub of technological innovation, where investments in both centralized and decentralized diagnostic tools are propelling market growth and transforming how patient care is delivered.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights on Leading Companies Shaping the Market

The cardiac POC testing arena is bolstered by contributions from several influential companies whose innovations and market strategies are redefining diagnostic excellence. Industry frontrunners such as Abbott Laboratories, ACON Laboratories, Inc., and Alfa Scientific Designs, Inc. have developed state-of-the-art diagnostic tools that combine sensitivity, specificity, and user-friendly interfaces. Other key players like Bio-Rad Laboratories, Inc., Cipla Limited, and Compagnie Merieux Alliance SAS are equally pivotal in expanding global reach and driving technology adoption.

Notable multinational corporations such as Danaher Corporation, F. Hoffmann-La Roche Ltd, and Medtronic plc continue to invest heavily in R&D to refine existing offerings and develop next-generation devices. Innovative enterprises like Getein Biotech, Inc., LifeSign LLC, and Nano-Ditech Corp. are making significant strides by introducing cutting-edge technologies that cater to emerging markets. Additional contributions from Nexus Dx, Inc., Nova Biomedical Corporation, and Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A. further underscore the highly competitive and collaborative nature of this market.

Each of these companies brings a unique blend of technological excellence and strategic market positioning. Their continued drive towards innovation, combined with an increasing emphasis on reliability and performance, is set to propel the overall growth of cardiac POC testing solutions across various clinical applications and geographies. These industry leaders not only shape market trends but also establish benchmarks that other players aspire to, continually encouraging advancements in the field.

The report delves into recent significant developments in the Cardiac POC Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Cipla Limited, Compagnie Merieux Alliance SAS, Danaher Corporation, F. Hoffmann-La Roche Ltd, Getein Biotech, Inc., Laboratory Corporation of America Holdings, LifeSign LLC, Medtronic plc, Merck KGaA, Nano-Ditech Corp., Nexus Dx, Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A.. Strategic Recommendations for Market Leadership

For industry leaders aiming to capitalize on the expanding cardiac POC testing landscape, a strategic approach that integrates innovation, market intelligence, and customer-centric service is essential. Based on current industry developments, it is recommended that companies invest robustly in research and development to pioneer next-generation diagnostic tools that offer enhanced accuracy and speed. Forming strategic partnerships with research institutions and technology innovators can lead to breakthrough improvements in device performance, particularly in the realm of miniaturization and integrated digital platforms.

Market leaders should also focus on building resilient supply chains and optimizing manufacturing processes to ensure rapid scalability and cost-effectiveness. Tailoring product portfolios to meet the specific requirements of segmented market groups-ranging from comprehensive biomarker tests to versatile devices suitable for both clinical and home settings-will be vital. Furthermore, leveraging data analytics to understand consumer behavior and regional disease patterns can provide a competitive edge in customizing solutions that address local healthcare challenges.

Emphasis should be placed on expanding market presence in regions with high growth potential while remaining adaptive to regulatory changes and technological advancements. Building strong customer support networks and training programs can ensure that new technologies are effectively implemented and sustained. By adopting a holistic and agile approach, companies can safeguard their market share and drive ongoing success in a competitive and evolving field.

Conclusion: Paving the Way for a Healthier Future

In conclusion, the landscape of cardiac POC testing devices is marked by rapid innovation, diverse clinical applications, and substantial growth opportunities. Technological advancements are continuously reshaping the industry, enhancing the accuracy and speed of diagnostic tests while providing critical support in both emergent and routine care settings. Detailed segmentation insights reveal the multifaceted nature of this market, from specialized biomarker tests to advanced device categories that cater to various clinical and home environments.

The regional dynamics underscore the importance of targeted strategies, given the differing regulatory frameworks, technological maturity, and healthcare infrastructures across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Furthermore, the active role of key market players is instrumental in setting industry standards and driving adoption through continuous innovation and strategic market expansion.

Ultimately, these insights not only provide a roadmap for current market trends but also highlight the pivotal role that strategic planning and technological integration play in shaping the future of cardiac care. As stakeholders work together to advance the state of diagnostic health, the collective efforts contribute significantly to improving patient outcomes and fostering a healthier, more proactive approach to cardiac management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiac disorders and rising geriatric population globally
      • 5.1.1.2. Inclination toward the early detection and diagnosis of patients
      • 5.1.1.3. Favorable government support for cardiac health
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of product recall in Cardiac POC testing devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Implementation of unique & new troponin-based test
      • 5.1.3.2. Positive investment and startup ecosystem
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations and concerns associated with the accuracy of cardiac POC testing devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Favorable regulatory approvals for various cardiac POC testing devices
    • 5.2.2. Device Type: Exploration of wearable POC devices to provide convenient homecare for managing heart conditions
    • 5.2.3. Application: Critical role played by effective diagnostics & screening procedures in the management of cardiac diseases
    • 5.2.4. End-User: Extensive and comprehensive care provided by hospitals for improving cardiac health
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac POC Testing Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Biomarker Test
    • 6.2.1. B-Type Natriuretic Peptide
    • 6.2.2. Creatine Kinase-MB [CK-MB] Fraction
    • 6.2.3. D-dimer Tests
    • 6.2.4. Myoglobin Tests
    • 6.2.5. Troponin Tests
  • 6.3. Consumable & Accessories
  • 6.4. Devices
    • 6.4.1. Analyzers
    • 6.4.2. Imaging & Monitoring Devices

7. Cardiac POC Testing Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Bench-top POC Devices
  • 7.3. Handheld POC Devices
  • 7.4. Wearable POC Devices

8. Cardiac POC Testing Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Screening
  • 8.3. Monitoring

9. Cardiac POC Testing Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Home Settings
  • 9.5. Hospitals

10. Americas Cardiac POC Testing Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac POC Testing Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac POC Testing Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Siemens Healthineers launches NT-proBNPII assay on Atellica platform to enhance heart failure diagnosis and speed patient care
    • 13.3.2. F. Hoffmann-La Roche AG launches NT-proBNP point-of-care test on cobas h 232 to enhance early detection and management of CVD and heart failure in diabetes patients
    • 13.3.3. Analytics for Life and CorVista Health receive FDA clearance for non-invasive CorVista System with Pulmonary Hypertension
    • 13.3.4. Eko Health, Inc. and Mayo Clinic secure FDA clearance for AI-driven low ejection fraction detection
    • 13.3.5. SpinChip Diagnostics receives NOK 115 million investment from bioMerieux to commercialize next-generation cardiac POC testing devices
    • 13.3.6. Roche to acquire LumiraDx's microfluidic point-of-care technology to advance cardiovascular diagnostics
    • 13.3.7. Primary Healthtech's Mobilab device offers early detection of heart and chronic diseases with IoT integration
    • 13.3.8. EDX Medical Group Plc. acquires Hutano Diagnostics Ltd. to develop advanced smartphone-integrated POC tests
    • 13.3.9. EDX Medical Group acquires Hutano Diagnostics to revolutionize rapid healthcare tests with advanced diagnostic technology enhancing speed, accuracy, and cost-effectiveness
    • 13.3.10. Cipla launches cippoint, POC testing device to expand diagnostics portfolio with CE IVD approval, enhancing rapid clinical decision-making and market penetration
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. F. Hoffmann-La Roche Ltd.
    • 13.4.2. Siemens Healthineers AG
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Danaher Corporation
    • 13.4.5. Werfen, S.A.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Alfa Scientific Designs, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Cipla Limited
  • 6. Compagnie Merieux Alliance SAS
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Getein Biotech, Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. LifeSign LLC
  • 12. Medtronic plc
  • 13. Merck KGaA
  • 14. Nano-Ditech Corp.
  • 15. Nexus Dx, Inc.
  • 16. Nova Biomedical Corporation
  • 17. Polymer Technology Systems, Inc. by Sinocare
  • 18. Precision Biosensor, Inc.
  • 19. QuidelOrtho Corporation
  • 20. Sekisui Chemical Co., Ltd.
  • 21. Siemens Healthineers AG
  • 22. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. CARDIAC POC TESTING DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIAC POC TESTING DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIAC POC TESTING DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 24. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. CARDIAC POC TESTING DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CREATINE KINASE-MB [CK-MB] FRACTION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY D-DIMER TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CONSUMABLE & ACCESSORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMAGING & MONITORING DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BENCH-TOP POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HANDHELD POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WEARABLE POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTICS & SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 43. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 44. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 49. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 50. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 68. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 75. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 81. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 82. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 87. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 88. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 99. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 105. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 106. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 111. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 112. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 117. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 118. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 123. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 124. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 129. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 130. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 135. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 136. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 141. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 142. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 147. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 148. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 160. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 166. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 167. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 172. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 173. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 178. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 179. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 184. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 185. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 190. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 196. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 197. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 202. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 203. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 214. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 215. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 220. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 221. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 226. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 227. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 232. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 233. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 238. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 239. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 244. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 245. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 250. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 251. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 262. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 263. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 268. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 269. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 280. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 281. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 282. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023